title: Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain.
authors.affiliation: Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: John S
authors.initials: JS
authors.lastname: McMurray
authors.forename: Pijus K
authors.initials: PK
authors.lastname: Mandal
authors.forename: Warren S
authors.initials: WS
authors.lastname: Liao
authors.forename: Zhiyong
authors.initials: Z
authors.lastname: Ren
authors.forename: Xiaomin
authors.initials: X
authors.lastname: Chen
mesh_terms: D045744:Cell Line, Tumor; D006801:Humans; D018716:Molecular Mimicry; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D010766:Phosphorylation; D011355:Prodrugs / Q000494:pharmacology*; D050796:STAT3 Transcription Factor / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D018909:src Homology Domains
chemical_list: D010455:Peptides; D011355:Prodrugs; D050796:STAT3 Transcription Factor